Saturday 17 October 2026
Export AUNA’s income statement to Excel — free account
Auna S.A.
AUNA Healthcare Medical Care Facilities
Auna S.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.27% from fiscal 2024. In the quarter to June 2026, revenue grew 20.5%, EPS fell 61.3%, free cash flow grew 121.1% and total debt rose 7.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.32
0.02
+0.38%
Follow AUNA
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Piotroski F-Score |
5 | — | — |
P/E ratio |
13.67 | 18.05 | 18.05 |
Altman Z-Score |
1.02 | 1.08 | — |
P/S ratio |
0.30 | 0.40 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.98 | 0.71 | 0.53 |
P/FCF ratio |
2.48 | 3.29 | 0.00 |
Beneish M-Score |
(2.69) | (2.81) | — |
P/Operating CF |
5.94 | 8.93 | 0.00 |
P/B ratio |
0.73 | 1.07 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
1.04 | 1.17 | 0.00 |
EV/EBITDA |
5.56 | 5.25 | 0.00 |
EV/Operating CF |
6.88 | 7.66 | 0.00 |
EV/FCF |
8.69 | 9.72 | 0.00 |
Quick Ratio |
0.84 | 0.67 | 0.71 |
Current Ratio |
1.11 | 0.88 | 0.92 |
Net Debt/EBITDA |
3.98 | 3.48 | 4.62 |
Debt/Assets |
49.69% | 52.75% | 50.56% |
Debt/Equity |
2.05 | 2.30 | 2.19 |
Asset Turnover |
0.63 | 0.59 | 0.00 |
Operating CF/Net income |
6.79 | 6.06 | (2.29) |
Capex/Depreciation |
(0.71) | (0.74) | (0.77) |
Interest Coverage |
0.96 | 1.32 | 0.71 |
| 5.90% | 6.48% | 0.00% | |
| 1.39% | 1.49% | 0.00% | |
ROIC |
7.77% | 9.77% | 6.57% |
Return on Tangible Assets |
3.96% | 5.41% | (10.44%) |
Average Days of Receivables |
86.79 | 80.05 | 81.07 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
23.57% | 22.48% | 23.18% |
Intangible Assets out of Total Assets |
0.37 | 0.38 | 0.41 |
Share Based Compensation of Revenue |
0.26% | 0.21% | 0.09% |
Graham Net Nets |
(2.84) | (2.17) | 0.00 |
Graham Number |
7.37 | 7.41 | 0.00 |
Earnings Yield |
7.32% | 5.54% | 5.54% |
Free Cash Flow Yield |
40.40% | 30.40% | 0.00% |
Revenue per Share |
16.63 | 17.36 | 23.60 |
Operating CF per Share |
2.51 | 2.65 | 3.55 |
Capex per Share |
(0.52) | (0.56) | (0.98) |
Free Cash Flow per Share |
1.99 | 2.09 | 2.57 |
Cash per Share |
1.39 | 1.37 | 2.04 |
Shareholders Equity per Share |
6.70 | 6.42 | 10.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
6.70 | 6.42 | 10.82 |
Free Cash Flow |
147.13 | 140.41 | 112.69 |
Working Capital |
49.80 | (64.33) | (37.48) |
Capital Expenditures |
(38.77) | (37.75) | (43.04) |
Net Current Asset Value |
(1,034.61) | (1,000.42) | (1,166.89) |
EV/EBIT |
7.29 | 6.54 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.04 |
Price to Operating Income |
2.08 | 2.21 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 |
Cash ROIC |
9.10% | 9.24% | 7.02% |
Accounts Receivable Turnover |
4.48 | 4.80 | 0.00 |
Accounts Payable Turnover |
2.81 | 3.16 | 0.00 |
Inventory Turnover |
18.06 | 19.37 | 0.00 |
Average Days of Payables |
141.27 | 127.75 | 112.07 |
Days of Inventory on Hand |
22.10 | 19.72 | 19.52 |
Average Receivables |
274.48 | 243.28 | — |
Average Payables |
271.88 | 224.28 | — |
Average Inventory |
42.28 | 36.61 | — |
Average Assets |
1,967.42 | 1,971.60 | — |
Average Common Equity |
464.08 | 453.78 | — |
Columns are period end dates